Trial Profile
Multicenter, prospective, observational study aimed at evaluating nabiximols effects (effectiveness and tolerability) in a large population of Italian multiple sclerosis patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Nov 2016
Price :
$35
*
At a glance
- Drugs Nabiximols (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions; Therapeutic Use
- Acronyms SA.FE.
- 18 Feb 2016 New trial record